Zybio Debuted at AACC 2023
July 27, 2023 Zybio News
-
May 30, 2025
DiagHub Online Academic Platform: The second session on Immunology Concludes Successfully
-
May 28, 2025
Conference Summary | 3rd Conference on Innovative Technology Applications in Laboratory Medicine: Exploring the Source of Mass Spectrometry, Advancing the Path of Innovation
-
May 23, 2025
Zybio at EuroMedLab 2025: Comprehensive Laboratory Solution with Constant Upgraded Technologies
The 75th AACC Annual Scientific Meeting & Clinical Lab Expo was held from July 25 to 27 in Anaheim, California, USA, which brought together more than 900 enterprises from over 100 countries and regions.
Before the opening of the exhibition, the organiser American Association for Clinical Chemistry (AACC) announced that it would officially change its name to Association for Diagnostics & Laboratory Medicine (ADLM).
Zybio presented laboratory solutions covering Microbiology , Urinalysis, CLIA, Chemistry, Molecular, POCT and Hematology at the Expo, debuted cutting-edge innovations that can screen diseases accurately and protect health in time.
Among the products on the display, Zybio's Microbiology (EXS2600) and Urinalysis Solution were rated as the most anticipated IVD solutions.
EXS2600 Ieverages the state of the Art Technology of MALDI-TOF MS, shining around the Exhibition, capable of meeting the requirement of microorganisms identification in an accuracy and efficiency way for the Clinial, Food industry, Scientific research and Etc.
Zybio's Urinalysis Solution utilizes Laminar Flow Imaging technology, which combines the advantages of both "Flow Cytometry" and "Digital Image" methods, achieving accurate quantification and classification, automatically identifying up to 25 items of formed particle classification.
To better serve our global customers, Zybio has been expanding our overseas market since 2018. To date, our product solutions and services are available in more than 100 countries in Asia, South America, North America, Europe and Africa, with over 20,000 clients globally using our products.
Remaining true to our mission of “Dedication to Accuracy”, Zybio will continue to cater to the unique needs of our customers, and enhance our innovation in the IVD industry. By deepening our cooperate with global medical institutions, we will strive to create greater value for our customers and build Zybio into an internationally renowned IVD brand.
For further information, please scan the QR codes above to follow us.